SRPT Q4 2018 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$84M+47.4% YoY

Gross Profit

$71M84.4% margin

Operating Income

-$139M-165.1% margin

Net Income

-$141M-166.9% margin

EPS (Diluted)

$-2.05

QoQ Revenue Growth

+7.6%

Cash Flow

Operating Cash Flow

-$122M

Free Cash Flow

-$143M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$610M

Stockholders' Equity

$1.0B

Cash & Equivalents

$371M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$57M	+47.4%
Gross Profit	$71M	$54M	+32.7%
Operating Income	-$139M	-$23M	-502.1%
Net Income	-$141M	-$24M	-487.1%